InvestSMART

Eli Lilly & Co (NYSE: LLY) - Share Price

Current share price for LLY : $1,142.850 7 (0.61%)+

Currency: USD ($)

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

LLY General Information +

NYSE Code LLY
Industry/Sector Drug Manufacturers - General
Market Cap ($M) 1,075,829
LLY Share Price $1,142.850
Day High $1,163.870
Day Low $1,136.900
Last Close $1,149.850
LLY Share Price Movement $7.00 ( 0.61% )
Prices as at 3:49, 3 Oct 2026
+Security prices are at best end-of-day and are indicative only.

Eli Lilly & Co (LLY) Upcoming Dividends & Yields

Currency Dividend Frequency of dividend payment Declare Date Record Date Payment Date
USD 0.58¢ Quarterly 22 Jun 2026 14 Aug 2026 10 Sep 2026

See all dividends from Eli Lilly & Co (LLY) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

LLY Financial Summary

Operating Revenue Per Share Price to Operating revenue Price to free cash flow Earnings Yield PE Ratio Dividend Yield Forward Dividend Yield Forward Earnings Yield
$35.98 $31.76 $75.57 2.59% 38.60 0.58 0.6 4.1

LLY Calendar of Events

Created Date Changed Date Event
22 June 2026 22 June 2026 Dividend

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.